Home dialysis and Covid-19 in french speaking countries (RDPLF data-base)

Focus on peritoneal dialysis

Authors

DOI:

https://doi.org/10.25796/bdd.v4i3.63003

Keywords:

Covid-19, SARS-Cov2, Home dialysis, Peritoneal dialysis, mortality, lethality, French speaking countries

Abstract

Aims of the study: to assess the frequency of symptomatic Covid-19 in home dialysis patients and its influence on the number of patients treated at home in dialysis units of centers included in the French-speaking peritoneal and home hemodialysis Registry (RDPLF). Focus is placed on patients treated by peritoneal dialysis (PD) in mainland France.

Results: in home hemodialysis (HHD)the incidence is 6% in Belgium and 4.8% in mainland France. On peritoneal dialysis it is 10.6% in Belgium, 6.7% in mainland France, 10.8% in Morocco and 11.5% in Tunisia. Lethality is less than 5% in HHD and between 8.4% and 42.7% in PD depending on age and associated comorbidities. In France, the percentage of patients who have had symptomatic Covid-19 is lower on home dialysis, all methods combined. Nevertheless, among the home methods, the higher frequencies and severities are observed in mainland France in home assisted PD: these are the oldest and most co-morbid patients. Transfers from PD to in center hemodialysis have increased during Covid-19 pandemic while the number of transplants has decreased.

Conclusion: if the drop in the number of transplants can be explained by a reduced availability of operating theaters and surgical teams during a pandemic period, it is paradoxical that the prescription of home dialysis, which should be supposed to limit the risk of contagion, has decreased. More investigation should be performed to understand this paradox.

 

References

1. Verger C, Fabre E, Veniez G, Padernoz MC. Synthetic 2018 data report of the French Language Peritoneal Dialysis and Home Hemodialysis Registry (RDPLF). Bulletin de la Dialyse à Domicile. 2019;2(1):1-10.
2. Verger C, Veniez G, Padernoz M-C, Fabre E. Home dialysis in french speaking countries in 2020 (RDPLF database). Bulletin de la Dialyse à Domicile. 2021;4(1):55-70.
3. Li PK-T, Szeto CC, Piraino B, De Arteaga J, Fan S, Figueiredo AE, et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2016;36(5):481-508.
4. Pizarro-Sánchez MS, Avello A, Mas-Fontao S, Stock Da Cunha T, Goma-Garcés E, Pereira M, et al. Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients. Kidney and Blood Pressure Research. 2021:1-9.
5. Lucas Pierre-Michel J, Collart F, Baudoux T, Bonvoisin C, De Smet J-M, Devresse A, et al. Has Covid-19 reduced the management of end-stage kidney disease in 2020? Bulletin de la Dialyse à Domicile. 2021;4(1):53-4.
6. Robinson BM, Guedes M, Alghonaim M, Cases A, Dasgupta I, Gan L, et al. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion. Kidney Medicine. 2021;3(4):619-34.
7. Biomédecine Ad. Situation de l’épidémie de Covid-19 chez les patients dialysés et greffés rénaux en France au 18 Aout 2021. Bulletin numéro 61 du registre REIN [Internet]. 2021; (61). Available from: https://www.agence-biomedecine.fr/IMG/pdf/bulletin_no61_version1.pdf.
8. Couchoud C, Verger C. Symptomatic SARS-CoV2 infections in patients treated in France by hemodialysis in an establishment, or at home or by peritoneal dialysis: Data from the REIN and RDPLF registry. Bulletin de la Dialyse à Domicile. 2020;3(4):213-26.
9. Michel P-A, Piccoli GB, Couchoud C, Fessi H. Home hemodialysis during the COVID-19 epidemic: comment on the French experience from the viewpoint of a French home hemodialysis care network. Journal of Nephrology. 2020;33(6):1125-7.
10. Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. Journal of Nephrology. 2021;34(4):985-9.
11. Canney M, Er L, Antonsen J, Copland M, Singh RS, Levin A. Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter. Canadian Journal of Kidney Health and Disease. 2021;8:205435812098626.
12. Durand P-Y, Verger C. The State of Peritoneal Dialysis in France. Peritoneal Dialysis International. 2006;26(6):654-7.
13. Couchoud C, Savoye E, Frimat L, Ryckelynck JP, Chalem Y, Verger C. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int. 2008;28(5):509-17.

Published

2021-09-09

How to Cite

1.
Verger C, Fabre E, Durand P-Y, Chanliau J, Vernier I, Dratwa M. Home dialysis and Covid-19 in french speaking countries (RDPLF data-base): Focus on peritoneal dialysis. Bull Dial Domic [Internet]. 2021 Sep. 9 [cited 2024 Dec. 22];4(3):227-3. Available from: https://bdd.rdplf.org/index.php/bdd/article/view/63003